<DOC>
	<DOC>NCT00929708</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy, safety and tolerability of 4 weeks treatment with AZD3199 in moderate to severe COPD.</brief_summary>
	<brief_title>Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>AZD-3199</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>COPD Current or exsmokers, 10 pack years Asthma Any clinically relevant abnormal findings at screening examinations Recent COPD exacerbation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Inhalation</keyword>
</DOC>